chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient started complaining of chest pain and dizziness shortly after getting the vaccine. EKG was obtained. Blood pressures were taken 87/58 P:103. Attending provider was notified. Patient was discharged from clinic 1 hour post injection.
left armpit and left breast lymph node swelling; left armpit and left breast lymph node swelling and still hurting; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration in the left arm on 15Jan2021 at 09:15 (at the age of 50-years-old) as a single dose for COVID-19 immunization. Medical history included the patient was a diabetic; penicillin, crustacean, rye, wheat and barley allergy; and COVID-19 diagnosed prior to the vaccination. Concomitant medications included metformin, atorvastatin, dapagliflozin propanediol monohydrate (FARXIGA) and an unspecified hormone replacement. The patient did not receive any other vaccines within 4 weeks prior to the vaccination. On 15Jan2021 at 13:00, the patient experienced left armpit and left breast lymph node swelling, which was still hurting and swelling at the time of this report. The events resulted in a doctor or other healthcare professional visit. The patient was treated with ibuprofen (ADVIL) every 6-8 hours for pain. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of left armpit and left breast lymph node swelling and still hurting was not resolved at the time of this report.  information on the lot/batch number has been requested.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 61-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 09May2022 at 13:00 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 60 years, in right arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Follicular lymphoma" (unspecified if ongoing). The patient's concomitant medications were not reported. The patient had no other medication in 2weeks. Past drug history included: Sulfur, reaction(s): "Known allergies: Sulfur". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19. The patient received the anti-viral treatment with Paxlovid, started on 08Oct2022 and stopped on 12Oct2022.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
It felt like a bad cold, low-grade, with a cough, congestion, I lost my sense of taste and smell. I took a home COVID-19 test, that came back positive. I called my doctor to let him know that I had tested positive for COVID-19 and discuss my symptoms. He prescribed the PAXLOVID antiviral, I started feeling better within four days. I did have a lingering cough that took a couple a more weeks to leave.
Pt stated having a rash on the right side of his neck/upper right side of chest 10 days after 1st dose and after his second dose the rash spread to the left side and is itchy. Pt seen in clinic 4 Oct 21, unkonwn if rash is result of vaccine series.
Reaction; This spontaneous case was reported by a consumer and describes the occurrence of UNEVALUABLE EVENT (Reaction) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced UNEVALUABLE EVENT (Reaction). At the time of the report, UNEVALUABLE EVENT (Reaction) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Aspiration pneumonia; This is a spontaneous report from a Pfizer sponsored program  from a contactable pharmacist.   A female patient of an unspecified age received the first dose of BNT162B2 (Pfizer-Biontech Covid-19 Vaccine) at single dose, on an unspecified date, in Jan2021, for COVID-19 immunisation. Relevant medical history and concomitant medications were unknown. On 09Feb2021, the patient experienced aspiration pneumonia but no fever and on antibiotic. Clinical outcome was unknown at time of this report.   The information on the lot number has been requested.; Sender's Comments: Event aspiration pneumonia represents a coincidental medical condition unrelated to the vaccine use.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Chronic Urticaria after food ongoing all over body, face, hands, feet. Tried Benadryl and Zyrtec with no effect. Ended up in ER 2x. 2nd was with angioedema of both lips treated with Steroid drip and benadryl drip no effect. Have been prescribed 10mg Doxepin, Prednisone 20mg, Mupirocin and Triamcinolone cream both ineffective. Had one treatment of Xolair but no noticeable effect. Taking Allegra 24 hr and have to up the dose to 2x a day. Hives ongoing and getting worse.
Information has been received from a physicians assistant concerning a 25 year old female with a skin disorder who on 04-OCT-2007 was vaccinated with a 0.5 ml first dose of GARDASIL vaccine (yeast) (Lot #658488/1264U). Concomitant therapy included unspecified antibiotics. On 05-OCT-2007 the patient experienced "a generalized rash all over the body". The patient was referred to a dermatologist. Unspecified medical attention was sought. At the time of the report the patient's outcome was unknown. Additional information has been requested. This is in follow-up to report(s) previously submitted on 11/14/2007. Initial and follow-up information has been received from a physicians assistant concerning a 25 year old female with a skin disorder who on 02-OCT-2007 at 09:13 was vaccinated intramuscularly into the right deltoid with a 0.5 ml first dose of GARDASIL (Lot #658488/1264U). Concomitant therapy included unspecified antibiotics. On 04-OCT-2007 the patient experienced "a generalized rash all over the body" (itchy hives). The patient was referred to a dermatologist. Unspecified medical attention was sought. At the time of the report the patient's outcome was unknown. Additional information is not expected.
Patient reported to pharmacy on 11/02/2019 stating that she was still feeling pain at the site of injection
had a reaction to the second dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (had a reaction to the second dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On an unknown date, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. On an unknown date, the patient experienced ADVERSE REACTION (had a reaction to the second dose). At the time of the report, ADVERSE REACTION (had a reaction to the second dose) outcome was unknown.            Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (reaction) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On an unknown date, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. On an unknown date, the patient experienced ADVERSE REACTION (reaction).            This case was linked to MOD-2021-034310, MOD-2021-034310 (Patient Link).   Reporter did not allow further contact   This case was linked to MOD-2021-034310, MOD-2021-034310 (Patient Link).   Reporter did not allow further contact
dose given more than 24 hours after the vial was first punctured; This spontaneous case was reported by a medical assistant and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (dose given more than 24 hours after the vial was first punctured) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 052E21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Aug-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (dose given more than 24 hours after the vial was first punctured). On 25-Aug-2021, EXPIRED PRODUCT ADMINISTERED (dose given more than 24 hours after the vial was first punctured) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant and treatment information provided.
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. On an unknown date in 2010, the patient was inoculated with ZOSTAVAX (lot number, dosage and route of administration not provided), as recommended for routine adult health maintenance for the prevention of shingles. The ZOSTAVAX did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster, also known as shingles and other complications. On an unknown date later in 2010, the patient was treated for a blistering vesicular outbreak that was diagnosed as severe herpes zoster or shingles. The outcome of the events is unknown. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Body ache; pyrexia; tachycardia; anxiety; below the site of injection was all red; injection site redness; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Body ache), ERYTHEMA (below the site of injection was all red), INJECTION SITE ERYTHEMA (injection site redness), ANXIETY (anxiety) and PYREXIA (pyrexia) in a 39-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 07-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-May-2021, the patient experienced ERYTHEMA (below the site of injection was all red) and INJECTION SITE ERYTHEMA (injection site redness). On 06-Jul-2021, the patient experienced ANXIETY (anxiety). On an unknown date, the patient experienced MYALGIA (Body ache), PYREXIA (pyrexia) and TACHYCARDIA (tachycardia). On 10-May-2021, ERYTHEMA (below the site of injection was all red) had resolved. At the time of the report, MYALGIA (Body ache) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No Concomitant  medications were reported.   Treatment information was not provided.   This case was linked to MOD-2021-248714 (Patient Link).
This spontaneous report as received from a pharmacy technician concerning a currently 16 months old child. Gender was not reported. Medical history and concurrent conditions were not reported. On 11-MAR-2014, the patient was vaccinated with VARIVAX (Merck) lot #J007955; expiration date: 27-JUN-2015, (dose, strength and route were not reported). Secondary and concomitant therapies were not reported. Patient was vaccinated with VARIVAX (Merck) that was exposed to 43.1 degrees F for 29 hours on 03-MAR-2014. This is one of several reports from the same reporter. Additional information has been requested.
10 days after 3rd vaccine (booster) experienced itchy scalp, rash/hives then spread throughout the rest of the body over the course of the next few days. Has been over two months with these symptoms and only getting worse.  Diagnosed with chronic uticaria and dermatographia. No other reason or explanation. Have to stay on high doses of allergy meds to function.
I gave PEDIARIX and Hepatitis B. I should have given Hib (PEDVAX) instead of Hep B.
I am being treated through medication for A-Fib of which I've had 0 episodes since August 9th, 2021. I received the Covid Moderna shot on 1/29/2021 at noon. That night and into the following morning I experienced 3 A-Fib episodes. . I have not had any since then.
PATIENT RECEIVED THE 5TH DOSE BEFORE THE TWO MONTH INTERVAL.  PREVIOUS MODERNA MONOVALENT DOSE WAS GIVEN ON 8/25/22.  LOT 082B22A.
Information has been received from a 68 year old female with early heart beat; arthritis and thrush from an antibiotic who on 06-MAR-2009 was vaccinated with a 0.65 mL first dose of ZOSTAVAX vaccine (Merck), subcutaneously. There was no concomitant medication. Within 3 weeks after getting the ZOSTAVAX vaccine (Merck) dose the patient stated that she developed a "sore on my ring finger on my left hand between the last knuckle and the cuticle that looked like a burn". The reporter also stated that "the redness is gone but there are little bubbles where the sore was, and the skin has been peeling off". No laboratories studies performed. The patient sought unspecified medical attention. At the time of this report the patient was recovering. Additional information is not expected.
Patient with a h/o multivessel disease and endstage CHF presented to ED c/o worsening SOB.  Patient reported getting SOB on exertion.   In the ED the patient was hypotensive and tachycardia, troponin elevated, heparin qtt started, and levophed drip started per cardiology.  Patient also tested positive for Covid-19.   For concerns of sepsis, Vanc and Zosyn started.  Echocardiogram revealed EF <25%, left atrium severely dilated, and severe mitral regurgitation.  On 05/26/2022 patient becoming more hypotensive, MAP was not maintained with levophed and dobutamin qtts.  Patient made comfort care on 05/27/2022 and expired on 5/29/2022.
rt arm area around inject-fist sized, swollen, red, warm to touch; 2 wks later, still swollen & sore & warm to touch but improving;
Constipation, abdominal cramping, excess gas, inconsolable crying, decrease in appetite, insomnia. The symptom kept building for two weeks until he went almost 24 hours without sleep. Then suddenly things started to get better. We had to administer several suppositories after 6 days of no bowel movements. We also gave him gas drops (Mylicon) to try to relieve his discomfort.
Vaccine administered at  Mega Site   Lot EL9266.  2/16/21 Sore arm for one day following first shot.   Lot EN6206.  3/9/21 Sore arm a few hours after second shot. Woke up with body aches and stuffy nose and swollen eyes. Lasted approx 24 hrs
Pt recv vax on 10/25/98; within 24 hr pt exp paleness, discolored rash of LA
White splotches to bilateral arms. Is treating with OTC antihistamines and creams with no relief of symptoms
Patient experienced a syncope fall from sitting position and fell to his left side. Pt stated being scared of needles and stated he had fainted from getting blood drawn or getting injections in the past. Pt denied any medical history or taking any medications. Pt denied trouble breathing, dizziness or any allergic reactions.
I was concerned by my reaction to the SHINGRIX vaccine. I got the vaccine at a hospital pharmacy on Monday, 10/29/2018, at 5pm. I felt some mild tiredness right away so I drove straight home. At 8pm I felt like I needed water, I had the chills and my teeth were chattering so I sat down with a blanket. From 9 to 11pm I felt very tired and wanted to go to bed but didn't have the strength to get up. At 11:30 I finally got up, drank more water and went to bed. I woke up at 2am Tuesday needing to go the bathroom but I was so cold that I waited as long as I could. When I finally got up I felt dizzy and stuffy and had a moderate headache. At 6am I again woke up. My feet and hands weren't normal. My feet could barely hold me up and my hands couldn't grip. I was much dizzier, stuffiness made it hard to breathe, and the splitting headache was the worst I've ever had. I finally stumbled to the kitchen, made a cup of tea and drank it. My feet and hands were working better but the headache and other symptoms were so bad that I went back to bed. At 12:30 pm I woke up with a moderate headache, dizziness, and nausea. I wrote down my symptoms and called the pharmacist who had administered the vaccine. She said my symptoms had been reported by other people and recommended that I get the second vaccine in two months. I then went back to bed. I woke up at 6pm with only minor headache and dizziness, was able to eat some chicken soup and watch TV. I went to bed at 11pm. The fever passed sometime in the night. I woke up Wednesday morning wet from sweat, and feeling weak. The head congestion drained that afternoon. On Thursday I still felt a little weak. Friday I felt back to normal. The FDA telephone number was on the paperwork from the pharmacy; I called and they gave me helpful info and said I should report to VAERS because of the severity of my symptoms. I also reported my symptoms to my doctor who prescribed the vaccine. She advised me not to get the second dose.
pt recv vax 24JUN96 & was unaware that was 2wk pregnant @ that time;subsequently began passing blood clots or tissue;MD not sure what was causing this;tx saw OB-GYN specialist;pt is considering terminating pregnancy;
PATIENT STATED THAT SHE PASSED OUT 12  HOURS AFTER RECEIVING DOSE.  THEN ABOUT 18 HOURS AFTER DOSE, EXPERIENCED VERTIGO, HEADACHE AND CHILLS FOR 72 HOURS.  SHE ALSO STATED THAT SHE PASSED BROWN URINE APPROXIMATELY 24 HRS AFTER DOSE
flu; Initial information was received on 22-Nov-2020 regarding an unsolicited valid non-serious case from a non-health care professional (patient's friend) via social media.  This case involves a patient of unknown demographics who had flu (influenza), while being vaccinated with INFLEUNZA VACCINE.  The patient's medical history, past medical treatment, vaccination, family history and concomitant medication were not reported.   On an unknown date, the patient received a dose of suspect influenza vaccine (produced by unknown manufacturer) (batch number and expiry date not reported) via unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, (latency: unknown) after being vaccinated with the INFLUENZA VACCINE, the patient got the flu (influenza). Thee patient's friend reported  that the patient used to get the flu every year post vaccination with the flu shot.  No laboratory data was reported.  It was not reported if the patient received any corrective treatment.  At the time of reporting, outcome of the event was unknown.  There will be no information available regarding batch number in this case.
New swelling, redness and heat in the injection site.  This is new as it had gone away a couple of days after injection.
Severe pain at injection site, muscles of outer upper right arm.  Immobility of right arm.   By 06/07/2021 , little change.  Range of possible motion only 30% of normal.  Severe pain and (arm "not working") outside of 30% range of motion.
I Started developing dry cough which 2 weeks later turned into sinus congestion as well. I went to my allergist who treats my conditions, and she diagnosed me with sinus infection.  I started a dosage of antibiotics and steroids. It is unsure if it?s related but it was relatively close to the vaccine so I thought I would mention it.
Migraine; My headache is bad; Fever; The initial case was missing the following minimum criteria: identifiable Event. Upon receipt of follow-up information on 08Jun2021, this case now contains all required information to be considered valid.  This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on 06Jun2021 as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. Patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on unspecified date as dose 1, single for covid-19 immunization. Consumer stated, I just have a question, I got a second dose of Pfizer and on last Saturday it is a 06Jun2021 about two days ago and on Sunday I got a fever on 07Jun2021 but today on 08Jun2021 I have a migraine and today I think my migraine my headache is bad. She just wanted to know if you could take I think migraine medicine after the COVID Shot. The outcome of event was unknown.  Follow-up attempts are completed. No further information is expected.
The Vanish point needle malfunctioned during vaccine administration causing some of the vaccine to leak out of the syringe.  The patient received more than half the dose.
This spontaneous report was received from a physician via field employee refers to a patient of unknown demographics. Information on pertinent medical history and allergies were reported as unknown. On an unknown date, physician reported that the patient was vaccinated with first dose of GARDASIL 9, intramuscular injection (dose was not reported) for prophylaxis. On an unknown date, patient received second dose and the patient passed out. The patient's mother (demographics unknown) refused the third dose. The outcome of passed out was reported as unknown. Upon internal review, the event of loss of consciousness was considered to be medically significant. Additional information has been requested.